IovanceBio· @IovanceBio · X·· 4 天前评分60
正文 · 原文
Madrid, here we come! 🇪🇸 Iovance’s 5 abstracts at #ESMO26 (Oct 23–27) showcase the TIL platform, including 2 orals in frontline advanced melanoma 🔬 and refractory soft tissue sarcomas 🧬 Details here: https://t.co/KcexlTTiTN https://t.co/CQ1M6BCFyU
热度 85 · 72 赞 · 0 回复 · 13 转发
来源：IovanceBio · x.com